retatrutide side effects phase 2 trial The Effect of on Kidney Parameters in Participants With Type Diabetes Mellitus and/or Obesity Retatrutide, an Amazing Future for

How Klinic Can Help At Klinic, our medical weight loss program is designed to be flexible and patient-centered

As a triple receptor agonist, retatrutides ability to target multiple pathways at once sets it apart from traditional treatments and has generated a lot of interest in the research and medical communities

Symptoms such as ongoing fatigue, weight gain despite treatment, or cold intolerance may indicate suboptimal thyroid hormone replacement, which should be addressed before starting weight management therapy

You will also have a video visit with one of our expert licensed registered dietitians

Data from the STEP trials demonstrate that weight loss often increases as the dose increases, with significant reductions typically occurring between months 2 and 6 of treatment